pharmaceuticals
pharmaceuticals Articles
AnaptysBio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
BeyondSpring has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Teva Pharmaceutical Industries released a mixed third-quarter earnings reports before the markets opened on Tuesday.
Published:
Last Updated:
Teva Pharmaceuticals has so far been unable to escape its rough patch in 2016. However there may now be a light at the end of the tunnel, considering the election results.
Published:
Last Updated:
Corbus Pharmaceuticals shares skyrocketed on Monday morning after the company announced positive results from its mid-stage clinical trial in systemic sclerosis.
Published:
Last Updated:
With the Republicans now set to control both Congress and the White House, many on Wall Street feel that there could be far less scrutiny on drug pricing.
Published:
Last Updated:
PTC Therapeutics shares skyrocketed early on Friday after the company received positive news from the European Medicines Agency.
Published:
Last Updated:
Gilead Sciences has announced that the FDA has approved its once-a-day treatment for adults with chronic hepatitis B virus infection.
Published:
Last Updated:
Shares of Anthera Pharmaceuticals lost roughly one-third of their value on Thursday after the company gave an update on its late-stage Lupus clinical trial.
Published:
Last Updated:
Drug prices have been under pressure due to the campaign rhetoric, and short interest has increased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
Sucampo Pharmaceuticals reported better-than-expected third-quarter financial results before the markets opened on Wednesday.
Published:
Last Updated:
Ionis Pharmaceuticals reported disappointing third-quarter financial results before the markets opened on Wednesday.
Published:
Last Updated:
Visterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Arrowhead Pharmaceuticals shares plummeted early on Wednesday after the company gave an update on its hepatitis B virus treatment.
Published:
Last Updated:
24/7 Wall St. has identified several immediate winners from a Donald Trump presidency. These are all surging higher.
Published:
Last Updated: